Xentuzumab
Product Specifications
CAS Number
1417158-65-6
Target
Akt, IGF-1R
Related Pathways
PI3K/Akt/mTOR signaling, Tyrosine Kinase/Adaptors, Cytoskeletal Signaling
Purity
0.9521
Bioactivity
Xentuzumab (BI836845) is a recombinant monoclonal antibody to humanised IGF ligand that inhibits IGF1 and IGF2 growth-promoting signalling and inhibits AKT activation for the study of solid tumours.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
S1013-88K5 200 µL
SIRT6, CT (NAD-dependent Deacetylase Sirtuin-6, SIR2-like Protein 6, SIR2L6)
Sign In for Pricing
View Details 
MT08792-01 1 g
1,2,3-Tri-O-benzyl-4,6-O- (4-methoxybenzylidene) -a-D-mannopyranoside
Sign In for Pricing
View Details MT08792-02 2 g
1,2,3-Tri-O-benzyl-4,6-O- (4-methoxybenzylidene) -a-D-mannopyranoside
Sign In for Pricing
View Details MT08792-03 5 g
1,2,3-Tri-O-benzyl-4,6-O- (4-methoxybenzylidene) -a-D-mannopyranoside
Sign In for Pricing
View Details